| Ident. | Authors (with country if any) | Title |
|---|
| 000190 (2019) |
Priscila Maria Aranda Salomão [Brésil] ; Flávia Amadeu De Oliveira [Brésil] ; Daiana Moreli Soares Dos Santos [Brésil] ; João Paulo Domezi [Brésil] ; Thiago José Dionísio [Brésil] ; Rodrigo Cardoso De Oliveira [Brésil] ; Ana Carolina Magalhães [Brésil] | TiF4 and NaF varnishes induce low levels of apoptosis in murine and human fibroblasts through mitochondrial Bcl-2 family and death receptor signalling. |
| 000216 (2019) |
Xuanyi Meng [Canada, République populaire de Chine] ; Garett Dunsmore [Canada] ; Petya Koleva [Canada] ; Yesmine Elloumi [Canada] ; Richard You Wu [Canada] ; Reed Taylor Sutton [Canada] ; Lindsy Ambrosio [Canada] ; Naomi Hotte [Canada] ; Vivian Nguyen [Canada] ; Karen L. Madsen [Canada] ; Levinus A. Dieleman [Canada] ; Hongbing Chen [République populaire de Chine] ; Vivian Huang [Canada] ; Shokrollah Elahi [Canada] | The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn. |
| 000276 (2019) |
Seema A. Patil [États-Unis] ; Mark H. Flasar [États-Unis] ; Jay Lin [États-Unis] ; Melissa Lingohr-Smith [États-Unis] ; Martha Skup [États-Unis] ; Song Wang [États-Unis] ; Jingdong Chao [États-Unis] ; Raymond K. Cross [États-Unis] | Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease. |
| 000322 (2019) |
Kari M. Ersland [Norvège] ; Lene S. Myrmel [Norvège] ; Even Fj Re [Norvège] ; Rolf K. Berge [Norvège] ; Lise Madsen [Norvège, Danemark] ; Vidar M. Steen [Norvège] ; Silje Skrede [Norvège] | One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects. |
| 000460 (2019) |
Deng-Long Li [République populaire de Chine] ; Bin Wu [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] ; Jing-Rong Cheng [République populaire de Chine] ; Dao-Bang Tang [République populaire de Chine] | Enhancing hemoglobin peptide production from chicken blood fermentation by food-grade nonionic surfactant. |
| 000520 (2019) |
Qiulan Luo [République populaire de Chine] ; Shiqing Zhou [République populaire de Chine] ; Xiaoshan Li [République populaire de Chine] ; Qubo Chen [République populaire de Chine] ; Wenmin Lin [République populaire de Chine] ; Liming Lu [République populaire de Chine] ; Hua Li [République populaire de Chine] ; Caifeng Chen [République populaire de Chine] ; Wenyong Chen [République populaire de Chine] ; Yunying Li [République populaire de Chine] | Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial. |
| 000542 (2019) |
Vineeta Shobha [Inde] ; S. Chandrashekara [Inde] ; Vijay Rao [Inde] ; Anu Desai [Inde] ; Ramesh Jois [Inde] ; Balebail G. Dharmanand [Inde] ; Sharath Kumar [Inde] ; Pradeep Kumar [Inde] ; Chethana Dharmapalaiah [Inde] ; Kurugodu Mathada Mahendranath [Inde] ; Shiva Prasad [Inde] ; Manisha Ashwin Daware [Inde] ; Yogesh Singh [Inde] ; Uma Karjigi [Inde] ; S. Nagaraj [Inde] ; K R Anupama [Inde] | Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India. |
| 000628 (2018) |
Ioannis Papalopoulos [Grèce] ; Antonis Fanouriakis [Grèce] ; Nikolaos Kougkas [Grèce] ; Irini Flouri [Grèce] ; George Sourvinos [Grèce] ; George Bertsias [Grèce] ; Argyro Repa [Grèce] ; Nestor Avgoustidis [Grèce] ; Prodromos Sidiropoulos [Grèce] | Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study. |
| 000706 (2018) |
Edimara S. Reis [États-Unis] ; Nadja Berger [États-Unis] ; Xin Wang [États-Unis] ; Sophia Koutsogiannaki [États-Unis] ; Robert K. Doot [États-Unis] ; Justin T. Gumas [États-Unis] ; Periklis G. Foukas [Grèce] ; Ranillo R G. Resuello [Philippines] ; Joel V. Tuplano [Philippines] ; David Kukis [États-Unis] ; Alice F. Tarantal [États-Unis] ; Anthony J. Young [États-Unis] ; Tetsuhiro Kajikawa [États-Unis] ; Athena M. Soulika [États-Unis] ; Dimitrios C. Mastellos [Grèce] ; Despina Yancopoulou [Grèce] ; Ali-Reza Biglarnia [Suède] ; Markus Huber-Lang [Allemagne] ; George Hajishengallis [États-Unis] ; Bo Nilsson [Suède] ; John D. Lambris [États-Unis] | Safety profile after prolonged C3 inhibition. |
| 000738 (2018) |
Thi Le Phuong Nguyen [Hongrie] ; Ferenc Fenyvesi [Hongrie] ; Judit Remenyik [Hongrie] ; Judit Rita Homoki [Hongrie] ; Péter Gogolák [Hongrie] ; Ildik Bácskay [Hongrie] ; Pálma Fehér [Hongrie] ; Zoltán Ujhelyi [Hongrie] ; Gábor Vasvári [Hongrie] ; Mikl S Vecsernyés [Hongrie] ; Judit Váradi [Hongrie] | Protective Effect of Pure Sour Cherry Anthocyanin Extract on Cytokine-Induced Inflammatory Caco-2 Monolayers. |
| 000778 (2018) |
Ryoko Sakai [Japon] ; Shoko Kasai [Japon] ; Fumio Hirano [Japon] ; Sayoko Harada [Japon] ; Mari Kihara [Japon] ; Waka Yokoyama [Japon] ; Michi Tsutsumino [Japon] ; Kenji Nagasaka [Japon] ; Ryuji Koike [Japon] ; Hisashi Yamanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon] | No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database. |
| 000782 (2018) |
Waleed Javed Hashmi [Pakistan] ; Hammad Ismail [Pakistan] ; Furrukh Mehmood [Pakistan] ; Bushra Mirza [Pakistan] | Neuroprotective, antidiabetic and antioxidant effect of Hedera nepalensis and lupeol against STZ + AlCl3 induced rats model. |
| 000783 (2018) |
Jinhao Tao [République populaire de Chine] ; Chen Shen [République populaire de Chine] ; Yanchun Sun [République populaire de Chine] ; Weiming Chen [République populaire de Chine] ; Gangfeng Yan [République populaire de Chine] | Neuroprotective effects of pinocembrin on ischemia/reperfusion-induced brain injury by inhibiting autophagy. |
| 000820 (2018) |
Nefyn H. Williams [Royaume-Uni] ; Alison Jenkins [Royaume-Uni] ; Nia Goulden [Royaume-Uni] ; Zoe Hoare [Royaume-Uni] ; Dyfrig A. Hughes [Royaume-Uni] ; Eifiona Wood [Royaume-Uni] ; Nadine E. Foster [Royaume-Uni] ; David Walsh [Royaume-Uni] ; Dawn Carnes [Royaume-Uni] ; Valerie Sparkes [Royaume-Uni] ; Elaine M. Hay [Royaume-Uni] ; John Isaacs [Royaume-Uni] ; Kika Konstantinou [Royaume-Uni] ; Dylan Morrissey [Royaume-Uni] ; Jaro Karppinen [Finlande] ; Stephane Genevay [Suisse] ; Clare Wilkinson [Royaume-Uni] | Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC). |
| 000834 (2018) |
Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon] | Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. |
| 000872 (2018) |
Chih-Yang Huang [Taïwan] ; Fa-Lun Lee ; Shu-Fen Peng [Taïwan] ; Kuan-Ho Lin [Taïwan] ; Ray-Jade Chen ; Tsung-Jung Ho [Taïwan] ; Fu-Jen Tsai [Taïwan] ; Vijaya V. Padma [Inde] ; Wei-Wen Kuo [Taïwan] ; Chih-Yang Huang [Taïwan] | HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy. |
| 000904 (2018) |
Sajad Ahmad Wani [Inde] ; Amit Ranjan Sahu [Inde] ; Shikha Saxena [Inde] ; Kaushal Kishor Rajak [Inde] ; M. Saminathan [Inde] ; Aditya Prasad Sahoo [Inde] ; Sonam Kanchan [Inde] ; Aruna Pandey [Inde] ; Bina Mishra [Inde] ; D. Muthuchelvan [Inde] ; Ashok Kumar Tiwari [Inde] ; Bishnu Prasad Mishra [Inde] ; Raj Kumar Singh [Inde] ; Ravi Kumar Gandham [Inde] | Expression kinetics of ISG15, IRF3, IFNγ, IL10, IL2 and IL4 genes vis-a-vis virus shedding, tissue tropism and antibody dynamics in PPRV vaccinated, challenged, infected sheep and goats. |
| 000946 (2018) |
Puneet Gaitonde [États-Unis] ; Felipe K. Hurtado [États-Unis] ; Parag Garhyan [États-Unis] ; Jenny Y. Chien [États-Unis] ; Stephan Schmidt [États-Unis] | Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials. |
| 000972 (2018) |
Kentaro Inui ; Tatsuya Koike ; Masahiro Tada ; Yuko Sugioka ; Tadashi Okano ; Kenji Mamoto ; Akira Sakawa ; Kenzo Fukushima [Japon] ; Hiroaki Nakamura | Clinical and radiologic analysis of on-demand use of etanercept for disease flares in patients with rheumatoid arthritis for 2 years: The RESUME study: A case-control study. |
| 000A02 (2018) |
Lianne Kearsley-Fleet [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Maya H. Buch [Royaume-Uni] ; John D. Isaacs [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] | Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. |
| 000A44 (2018) |
Anil Khushalrao Shendge [Inde] ; Tapasree Basu [Inde] ; Sourav Panja [Inde] ; Dipankar Chaudhuri [Inde] ; Nripendranath Mandal [Inde] | An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway. |
